Tag Archives: EXC

Top 10 Medical Stocks To Watch Right Now

Varian Medical Systems Inc (NYSE:VAR) files its latest 10-K with SEC for the fiscal year ended on September 30, 2017. Varian Medical Systems Inc is engaged in the healthcare sector. It manufactures medical devices for conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. Varian Medical Systems Inc has a market cap of $10.05 billion; its shares were traded at around $109.46 with a P/E ratio of 40.69 and P/S ratio of 2.98. Varian Medical Systems Inc had annual average EBITDA growth of 9.80% over the past ten years. GuruFocus rated Varian Medical Systems Inc the business predictability rank of 3-star.

For the last quarter Varian Medical Systems Inc reported a revenue of $739.0 million, compared with the revenue of $1.3 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $2.7 billion, a decrease of 17.1% from the previous year. For the last five years Varian Medical Systems Inc had an average revenue growth rate of 0.1% a year.

Top 10 Medical Stocks To Watch Right Now: The Hackett Group Inc.(HCKT)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, industrial shares were relative laggards, down on the day by about 0.20 percent. Meanwhile, top losers in the sector included The Hackett Group, Inc. (NASDAQ: HCKT), down 22 percent, and PC Tel Inc (NASDAQ: PCTI), down 18 percent.

Top 10 Medical Stocks To Watch Right Now: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    AbbVie Inc. (NYSE: ABBV), Pfizer Inc. (NYSE: PFE), Bristol-Meyers Squibb Co. (NYSE: BMY) and Johnson & Johnson (NYSE: JNJ) combine for over 22 percent of PILL's underlying index.

  • [By Kumar Abhishek]

    The lower number of patient starts and rising competition has been a major worry for Gilead Sciences Inc. Most of the patients with serious Hep-C conditions have already been cured.It is estimated that more than 1 million Hep-C patients have been cured worldwide. And the entry of competitively priced drugs will further dent the growth of this segment. Gilead’s HCV drugs are facing tough competition from Merck (NYSE:MRK), AbbVie (NYSE:ABBV) and Bristol-Myers Squibb (NYSE:BMY). For example, initially, the price difference between Merck’s treatment plan and Gilead’s plan was a whopping $40,000. The rising competition is also impacting the HCV segment’s margins.

  • [By Keith Speights]

    Smart investors will be ready to take advantage of a market pullback, whenever it comes and offers discount prices on great stocks. Three drug stocks appear to be excellent choices to buy on a dip: AbbVie (NYSE:ABBV), Allergan (NYSE:AGN), and Celgene (NASDAQ:CELG). Here’s why.

  • [By Craig Jones]

    Jon Najarian noticed high options volume in the November 205 calls in NVIDIA Corporation (NASDAQ: NVDA) ahead of earnings. He also spoke about unusual activity in AbbVie Inc (NYSE: ABBV). Traders were buying the November 91 calls in the name.

  • [By Todd Campbell]

    AbbVie, Inc.(NYSE:ABBV) is already awaiting a Food and Drug Administration decision on its next-generation successor to Viekira Pak, and that successor is easier to dose than Viekira Pak, can be given over as few as eight weeks, and delivers high cure rates across genotypes.Those advantages could help stabilize AbbVie’s hepatitis C market share, which has declined in the past year.

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

Top 10 Medical Stocks To Watch Right Now: Skechers U.S.A., Inc.(SKX)

Advisors’ Opinion:

  • [By Brian Withers] When the number one company in comfort-casual footwear,Skechers (NYSE:SKX) announced earnings last month, the headlines highlighted the first ever $1 billion quarter for the company. It seems investors weren’t impressed, though, as the stock continues to lag behind the market and has missed a nice run up over the past year.

  • [By Matt Hogan]

    Skechers USA Inc (NYSE: SKX) is expected to report earnings on Thursday after the market closes. The footwear company has generally traded lower over the last eight quarters in the face of decelerating revenue growth. The stock had been gaining some momentum in the early part of the year until Susquehanna's Sam Poser downgraded the company to a negative rating on March 29th. Poser warned that domestic wholesale growth would fall short of investor expectations and the stock has since fallen 15 percent.

  • [By Timothy Green]

    Shares of footwear company Skechers (NYSE:SKX) fell 18.6% in 2016, according to data provided byS&P Global Market Intelligence. A slowdown in growth and a string of mixed and negative earnings reports led investors to push down the stock.

  • [By Teresa Rivas]

    Skechers (SKX) is higher on Friday following its fourth-quarter earnings report.

    Getty Images

    Both the companys quarter and guidance were mixed, with higher-than-expected sales, but a downbeat bottom line. The shoe company said that it earned 4 cents a share on revenue that rose 5.8% year over year to $764.3 million. Analysts were expecting a dime per share in earnings on revenue of $726.2 million.

    For the first quarter, the company said it expects to earn between 50 cents and 55 cents a share, below the 66 cents analysts were expecting. However its revenue estimate of $1.05 billion to $1.08 billion was above the $1.05 that analyst are modeling for.

    Wedbushs Christopher Svezia reiterated Neutral rating and $25 price target on the stock, arguing that while hes encouraged by top-line trends, theyre coming at a cost. From his note:

    Shares will likely trade higher (+9% after hours) given the improved revenue outlook and what may have been a low bar on expectations. However, sales growth is not translating into earnings and the inflection continues to move further out, increasing risk should growth not materialize. We are maintaining our NEUTRAL rating and $25 price target or 14x P/E, a 10% discount to historical averages until we see visibility toward an inflection in earnings growth.

    Skechers is up 20% to $27.95 in recent afternoon trading.

  • [By Lee Jackson]

    Skechers USA Inc. (NYSE: SKX) was raised to Buy at a firm called Monness Crespi & Hardt, which put a $30 price target on the shares. Theconsensus price objective is$26.13, and the 52-week range is $18.81 to $34.27. The stock closed Thursday at a$24.05.

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.

Top 10 Medical Stocks To Watch Right Now: Beazer Homes USA, Inc.(BZH)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market performed well on Tuesday, responding to steady improvement among many companies as earnings season kicked into high gear. Although political issues are likely to remain in the spotlight for some investors for the foreseeable future, many market participants are looking to economic and business issues in driving their investing decisions. Major market benchmarks finished the day with gains of 0.5% to 1%, but some stocks did much better. Among the best performers on the day were Allegheny Technologies (NYSE:ATI), II-VI (NASDAQ:IIVI), and Beazer Homes (NYSE:BZH). Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Medical Stocks To Watch Right Now: ZAIS Group Holdings, Inc.(ZAIS)

Advisors’ Opinion:

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 48 percent to $3.35. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 42 percent to $3.22. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

Top 10 Medical Stocks To Watch Right Now: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Monica Gerson]

    Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

  • [By Casey Wilson]

    That brings us to General Electric Co. (NYSE: GE). The 125-year-old American mainstay signed a deal with Exelon Corp. (NYSE: EXC) last fall for the energy utility to use its own predictive analytics software, fittingly dubbed “Predix.”

  • [By Lisa Levin]

    Utilities shares climbed by 0.64 percent in trading on Friday. Meanwhile, top gainers in the sector included Exelon Corporation (NYSE: EXC), and FirstEnergy Corp. (NYSE: FE).

Top 10 Medical Stocks To Watch Right Now: GAIN Capital Holdings, Inc.(GCAP)

Advisors’ Opinion:

  • [By Lisa Levin]

    FXCM Inc (NASDAQ: FXCM) shares dropped 53 percent to $3.24 after the company announced regulatory settlements with NFA and CFTC against its U.S. subsidiary, Forex Capital Markets LLC. Gain Capital Holdings Inc (NYSE: GCAP) agreed to acquire the client base of FXCM's U.S. operations after FXCM reported that it will be withdrawing from U.S. business.

  • [By Lisa Levin]

    In trading on Friday, financial shares fell 0.16 percent. Meanwhile, top losers in the sector included Federated National Holding Co (NASDAQ: FNHC), down 11 percent, and Gain Capital Holdings Inc (NYSE: GCAP), down 7 percent.

Top 10 Medical Stocks To Watch Right Now: Celestica, Inc.(CLS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newsletter suggestion as the next breakout stock, andmid cap Flextronics International being bigger winners compared with the also good performance of mid cap Jabil Circuit, Inc (NYSE: JBL) and small cap Celestica Inc (NYSE: CLS):

  • [By Peter Graham]

    A long term performance chart shows shares of mid caps Jabil Circuit and Flextronics International Ltd (NASDAQ: FLEX) along with small capCelestica Inc (NYSE: CLS) and Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newslettersuggestion as the next breakout stock, all performing well recently as the tech stocks they supply outperform:

Top 10 Medical Stocks To Watch Right Now: Guess?, Inc.(GES)

Advisors’ Opinion:

  • [By Paul Ausick]

    Guess Inc. (NYSE: GES) posted a new 52-week low of $10.33 on Thursday, down about 15.5% compared with Wednesday’s closing price of $12.23. The stock’s 52-week high is $19.45. Volume was more than 7 times the daily average of around 1.3 million shares. The apparel maker missed quarterly estimates and the outlook for improvement is murky at best.

  • [By Peter Graham]

    Small cap apparel retailerGuess?, Inc (NYSE: GES) reportedearnings for Q3 Fiscal 2018 (ended October28, 2017) after the market closed on Wednesday with results mixed on anearnings beat, but weaker than anticipated revenue due to asharper decline than expected in North American year-over-year sales.Total net revenue increased 3.3% or 0.6% in constant currencyto $554.1 million, compared to $536.3 million in the prior-year quarter as:

  • [By Lisa Levin]

    Guess?, Inc. (NYSE: GES) was down, falling around 13 percent to $15.65. Guess? reported in-line earnings for its third quarter, while sales missed estimates. U.S. comps were down 10 percent.

Top 10 Medical Stocks To Watch Right Now: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Monica Gerson]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Citigroup Inc (NYSE: C) to report quarterly earnings at $1.16 per share on revenue of $17.34 billion before the opening bell. Citigroup shares rose 0.47 percent to $48.70 in after-hours trading.
    HP Inc (NYSE: HPQ) disclosed that it would be implementing a restructuring plan that would likely result in the firing of 3,000 to 4,000 employees, annual savings of $200 million to $300 million, and a charge of $350 million to $500 million. Management also announced a 7 percent surge in the stock’s dividend and an additional $3 million share repurchase program. The company issued its outlook for fiscal 2017, guiding for EPS of $1.55 to $1.65, mostly below the Street’s consensus of $1.64. HP shares fell 1.32 percent to $14.95 in the after-hours trading session.
    Analysts are expecting JPMorgan Chase & Co. (NYSE: JPM) to have earned $1.39 per share on revenue of $23.99 billion in the latest quarter. JPMorgan will release earnings before the markets open. JPMorgan shares gained 0.37 perecent to $67.99 in after-hours trading.
    Aerohive Networks Inc (NYSE: HIVE) reported weak preliminary results for its third quarter. The company said it expects a net loss of $(0.06) to $(0.07) per share, versus consensus at $(0.04) per share. Revenue guidance of $40 million also fell short of expectations for almost $48 million. Aerohive shares dropped 18.29 percent to $4.60 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin]

    Shares of Aerohive Networks Inc (NYSE: HIVE) were down 33 percent to $3.10. Aerohive Networks reported a Q2 loss of $3.9 million on revenue of $42.3 million, and disclosed that it has extended its $10 million buyback plan.

Top 10 Medical Stocks To Invest In 2018

Marijuana is well on its way to becoming the “norm” in modern America.

Eight states – Alaska, California, Colorado, Maine, Maryland, Massachusetts, Oregon, and Washington – and the District of Columbia have fully legalized possession of small amounts of marijuana for adults’ recreational use. An additional 13 states have decriminalized it. And 29 states, along with Puerto Rico and Guam, now allow the use of medical marijuana.

However, the drug is still classified as an illegal Schedule I substance in the eyes of the federal government.

Top 10 Medical Stocks To Invest In 2018: CareDx, Inc.(CDNA)

Advisors’ Opinion:

  • [By Lisa Levin]

    CareDx Inc (NASDAQ: CDNA) was down, falling around 25 percent to $1.61 after the company reported weak preliminary sales for fourth quarter and FY 2016.

Top 10 Medical Stocks To Invest In 2018: CRH Medical Corporation(CRHM)

Advisors’ Opinion:

  • [By Lisa Levin]

    CRH Medical Corp (NYSE: CRHM) was down, falling around 31 percent to $2.55 after the company disclosed financial and operating results for the quarter and six months ended June 30, 2017.

Top 10 Medical Stocks To Invest In 2018: Enphase Energy, Inc.(ENPH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    UPDATE: I stand corrected. There does appear to be a reason for First Solar’s market-leading move today. Axiom Capital’s Gordon Johnson attributes the rise to the $10 million investment in Enphase Energy (ENPH), which makes “microinverter systems for the solar photovoltaic industry,” by investors T.J. Rodgers and John Doerr.

Top 10 Medical Stocks To Invest In 2018: Ideal Power Inc.(IPWR)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewslettersuggested smallcap electrical power conversion product stock Ideal Power Inc (NASDAQ: IPWR)as a long trade:

Top 10 Medical Stocks To Invest In 2018: GigaMedia Limited(GIGM)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap online gaming and cloud computing GigaMedia Limited (NASDAQ: GIGM) as a bullish long trade:

Top 10 Medical Stocks To Invest In 2018: Neovasc Inc.(NVCN)

Advisors’ Opinion:

  • [By Lisa Levin] Related NVCN 18 Biggest Mid-Day Losers For Wednesday Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data Boston Scientific closes Neovasc transaction (Seeking Alpha)
    Related BSX Watch These 10 Huge Call Purchases In Monday Trade Wonderful Wearables Get Their Own ETF Boston Scientific closes Neovasc transaction (Seeking Alpha) Gainers
    Neovasc Inc (US) (NASDAQ: NVCN) rose 17.3 percent to $2.65 in pre-market trading after the company reported the close of its $75 million transaction with Boston Scientific Corporation (NYSE: BSX).
    aTyr Pharma Inc (NASDAQ: LIFE) shares rose 12.3 percent to $4.10 in pre-market trading after the company disclosed 'promising' signals in myopathies with Resolaris in exploratory trials.
    Globus Maritime Ltd (NASDAQ: GLBS) shares rose 10.1 percent to $6.90 in pre-market trading after climbing 5.03 percent on Monday.
    Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 9.9 percent to $3.00 in pre-market trading. Aurinia Pharmaceuticals appointed Lorin Jeffry “Jeff” Randall to its board and Chairman of the Audit Committee.
    Ocean Rig UDW Inc. (NASDAQ: ORIG) shares rose 8.7 percent to $2.89 in pre-market trading after surging 19.82 percent on Monday.
    Full House Resorts, Inc. (NASDAQ: FLL) shares rose 5.1 percent to $2.08 in pre-market trading after declining 1.98 percent on Monday.
    Seadrill Ltd (NYSE: SDRL) rose 5.1 percent to $4.13 in pre-market trading after surging 3.15 percent on Monday.
    Noble Corporation (NYSE: NE) rose 5.1 percent to $7.60 in pre-market trading after declining 5.37 percent on Monday.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 5.1 percent to $3.10 in pre-market trading. Arbutus issued additional data from its ARB-1467 Phase II
  • [By Lisa Levin]

    Neovasc Inc (US) (NASDAQ: NVCN) shares were also up, gaining 71 percent to $0.880 following announcement of an agreement with Boston Scientific Corporation (NYSE: BSX).

Top 10 Medical Stocks To Invest In 2018: Archer-Daniels-Midland Company(ADM)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Aflac (AFL) — yielding 2.5%
    Archer-Daniels Midland (ADM) — yielding 2.7%
    Chevron (CVX) — yielding 3.8%
    ExxonMobil (XOM) — yielding 3.6%
    Genuine Parts (GPC) — yielding 2.7%
    Johnson & Johnson (JNJ) — yielding 2.8%
    T. Rowe Price (TROW) — yielding 3.2%

Top 10 Medical Stocks To Invest In 2018: Barclays PLC(BCS)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Barclays PLC (NYSE: BCS) was raised to Overweight from Equal Weight at Morgan Stanley. Its American depositary sharesclosed up 2.6% at $11.36 on Thursday and were indicated up 1.2% at $11.50 on Friday. The52-week range is $6.76 to $12.05.

  • [By WWW.THESTREET.COM]

    Banco Santander (SAN) : “I prefer Barclays (BCS) , but let’s wait and see what the other banks have to say”

    ProLogis (PLD) : “I am not a fan of that group right now, but that one is best of breed.”

Top 10 Medical Stocks To Invest In 2018: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Horizon Investments]

    For the past year, Exelon Corp. (EXC) has had a roller coaster ride, with the stock having plummeted 15% since September 2012 – the company had announced a dividend cut of 41%, which led to a drop in the share price. Separately, the recent weak PJM auction prices did not bode well for the company. However, I believe the worst is priced in the stock price, and the company’s management is committed to improving its financial flexibility and cost structure in order to strengthen its financial performance. Also, the company is planning to incur capital expenditure (CAPEX) in the upcoming years, which will result in rate base growth for Exelon.

  • [By Casey Wilson]

    That brings us to General Electric Co. (NYSE: GE). The 125-year-old American mainstay signed a deal with Exelon Corp. (NYSE: EXC) last fall for the energy utility to use its own predictive analytics software, fittingly dubbed “Predix.”

  • [By Lisa Levin]

    Utilities shares climbed by 0.64 percent in trading on Friday. Meanwhile, top gainers in the sector included Exelon Corporation (NYSE: EXC), and FirstEnergy Corp. (NYSE: FE).

  • [By Monica Gerson]

    Analysts are expecting Exelon Corporation (NYSE: EXC) to have earned $0.68 per share on revenue of $7.52 billion in the latest quarter. Exelon shares rose 0.34 percent to close at $35.38 on Thursday.

  • [By Monica Gerson]

    Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

Top 10 Medical Stocks To Invest In 2018: T2 Biosystems, Inc.(TTOO)

Advisors’ Opinion:

  • [By Lisa Levin]

    T2 Biosystems Inc (NASDAQ: TTOO) shares were also up, gaining 15 percent to $7.48 after the company disclosed a $40 million equity investment by partner Canon U.S.A.

  • [By William Romov]

    Penny Stocks to Buy for December 2017, No. 5: T2 Biosystems Inc. (Nasdaq: TTOO)

    Currently trading at $4.10 per share, T2 Biosystems Inc. (Nasdaq: TTOO) makes diagnostic products for biological in vitro research. It has the highest share price of the penny stocks on our list today.

  • [By Lisa Levin]

    Shares of T2 Biosystems Inc (NASDAQ: TTOO) were down 29 percent to $5.41. T2 Biosystems extended timeline for the completion of the T2Bacteria trial. BTIG downgraded the rating on T2 Biosystems from Buy to Sell, while lowering the price target from $12 to $4.

financial trading

By Scott Tzu

It wasn’t just a couple of weeks ago that we wrote an article essentially defending Twitter (NYSE:TWTR) after Chief Operating Officer Adam Bain decided he was going to resign and move on. Twitter is almost already making us regret defending it because days later it has come out that the company issued a significant raise for Anthony Noto, who will be playing the role of both COO and CFO at the company. We’re not amused, and in this article, we’re going to talk about why.

It certainly is an interesting dynamic when you think of it, isn’t it? Here is a company that has a CEO who is splitting his time between two companies. Then, You have a CFO who up until this point has done a pretty good job, who will now be splitting his time with taking on the role of COO as well. We don’t think it is a bad idea for Noto to take on the role of COO in an interim fashion, but keeping him there with such permanence that would be a prompt to give him a substantial raise alarms us for a couple of reasons.

financial trading: Real Goods Solar, Inc.(RGSE)

Advisors’ Opinion:

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

  • [By Peter Graham]

    A long term performance chart shows Vivint Solar Holdings and fellow small cap solar installation stock Sunrun Inc (NASDAQ: RUN) below their IPO prices while Real Goods Solar, Inc (NASDAQ: RGSE)has imploded from its previous highs:

  • [By Peter Graham]

    A long term performance chart shows Vivint Solar Holdings along with small cap solar installation stock Sunrun Inc (NASDAQ: RUN) below their IPO prices while Real Goods Solar, Inc (NASDAQ: RGSE)has imploded after being a highflyer:

  • [By Lisa Levin]

    Shares of Real Goods Solar, Inc. (NASDAQ: RGSE) got a boost, shooting up 15 percent to $1.26 after the company issued a business update. RGS Energy expects Q1 sales of $1.96 million, up from $670,000 in the fourth quarter.

  • [By Lisa Levin]

    Shares of Real Goods Solar, Inc. (NASDAQ: RGSE) got a boost, shooting up 22 percent to $2.98 after dropping 7.89 percent on Monday. RGS Energy disclosed that it has completed its $11.5 million public offering of common stock and warrants.

financial trading: Medidata Solutions, Inc.(MDSO)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Veeva Systems outperformingunderperforming small cap peerModel N Inc (NYSE: MODN) while mid cap Medidata Solutions (NASDAQ: MDSO) has been a huge outperformer that has just moved past its 2014 peak:

  • [By Lisa Levin]

    On Wednesday, technology shares climbed by 0.94 percent. Top gainers in the sector included Marvell Technology Group Ltd. (NASDAQ: MRVL) and Medidata Solutions Inc (NASDAQ: MDSO).

financial trading: Berkshire Hathaway Inc.(BRK.A)

Advisors’ Opinion:

  • [By Diane Alter]

    The sector took off in November when 13F filings revealed Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A) bought shares in American Airlines Group Inc. (Nasdaq: AAL), United Continental Holdings Inc. (NYSE: UAL), Southwest Airlines Co. (NYSE: LUV), and Delta.

  • [By Sarfaraz Khan]

    Shares of Warren Buffett-ledBerkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B)delivered a blowout performance in 2016 by easily beating the S&P 500 (INDX:SPAL) and Dow Jones Industrial Average (INDX:INDU) and ending the year with a market cap of almost $400 billion for the first time in its history. And I believe the good times will continue in 2017.

  • [By Yasin Ebrahim]

    Berkshire Hathaway Inc. (NYSE:BRK.A) is an American conglomerate with investments in a variety of businesses from American Express to Coca-Cola. It reported Q3 earnings last week, which were in line with analysts expectations, as the group revealed a 7% increase in operating profit compared to the same period last year.

financial trading: Citizens Financial Group, Inc.(CFG)

Advisors’ Opinion:

  • [By ]

    Citizens Financial Group (NYSE: CFG) reports $152 billion in assets and a higher concentration of branches in the Northeast, but has a strong market share of 12% in its top ten metropolitan areas. Business is nearly evenly split between consumer lending (45%) and commercial loans (55%) and a technology investment program is driving a target for up to $60 million in cost savings by the end of 2018.

  • [By WWW.THESTREET.COM]

    Citizens Financial (CFG) was downgraded to neutral from outperform at Wedbush. The valuation is less attractive, based on a $31 price target, Wedbush said. 

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said he noticed a large call options volume in Citizens Financial Group Inc (NYSE: CFG). Around 13,000 contracts of the April 40 calls were traded in the first half of the trading session.

financial trading: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Utilities shares climbed by 0.64 percent in trading on Friday. Meanwhile, top gainers in the sector included Exelon Corporation (NYSE: EXC), and FirstEnergy Corp. (NYSE: FE).

  • [By Monica Gerson]

    Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

  • [By Monica Gerson]

    Analysts are expecting Exelon Corporation (NYSE: EXC) to have earned $0.68 per share on revenue of $7.52 billion in the latest quarter. Exelon shares rose 0.34 percent to close at $35.38 on Thursday.

  • [By Casey Wilson]

    That brings us to General Electric Co. (NYSE: GE). The 125-year-old American mainstay signed a deal with Exelon Corp. (NYSE: EXC) last fall for the energy utility to use its own predictive analytics software, fittingly dubbed “Predix.”

  • [By Horizon Investments]

    For the past year, Exelon Corp. (EXC) has had a roller coaster ride, with the stock having plummeted 15% since September 2012 – the company had announced a dividend cut of 41%, which led to a drop in the share price. Separately, the recent weak PJM auction prices did not bode well for the company. However, I believe the worst is priced in the stock price, and the company’s management is committed to improving its financial flexibility and cost structure in order to strengthen its financial performance. Also, the company is planning to incur capital expenditure (CAPEX) in the upcoming years, which will result in rate base growth for Exelon.

financial trading: TCF Financial Corporation(TCB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

Top 10 Stocks For 2018

Related GOOG This Biometric ID System Allows You To Buy Weed, Booze And Other Controlled Products From A Vending Machine Goldman Compares 'FAAMG' Stocks To High-Flyers Of The Dot-Com Bubble
Related GOOGL Here's Why Tech Stocks Fell Today Ever Had An App Idea? This Contest Can Make It Come To Life – And Even Bring In Some Cash Stocks End Mixed As 5 Names Spearhead The Tech Dive (Investor’s Business Daily)

Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) announced last week that Google chrome will automatically block all advertisements on sites that feature a certain level unacceptable ad formats identified by the Coalition for Better Ads, reported the Wall Street Journal.

Top 10 Stocks For 2018: GenMark Diagnostics, Inc.(GNMK)

Advisors’ Opinion:

  • [By Lisa Levin]

    GenMark Diagnostics, Inc (NASDAQ: GNMK) shares shot up 20 percent to $10.54. Cowen & Co. upgraded GenMark Diagnostics from Market Perform to Outperform.

Top 10 Stocks For 2018: Eagle Materials Inc(EXP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 1.10 percent. Meanwhile, top losers in the sector included Mechel PAO (ADR) (NYSE: MTL), down 8 percent, and Eagle Materials, Inc. (NYSE: EXP), down 6 percent.

  • [By David Sterman]

    Of course, in many cyclical industries, it’s impossible to maintain very strong growth rates when the economy slumps. And that was a lesson learned by Eagle Materials (NYSE: EXP(link is external)), a maker of drywall, cement and other materials used in homebuilding. Eagle experienced solid growth a decade ago, but when the housing market tanked, so did Eagle’s revenue base. Sales fell by half from fiscal 2007 through fiscal 2011 (to around $460 million).

    Yet even before the pace of home construction returns to normal levels, Eagle is again experiencing solid growth: Sales are now growing at a 30% pace and are expected to surpass $1.1 billion in the current fiscal year, which began this month. That’s 25% higher than the peak in fiscal 2007, and it’s setting the stage for solid profit growth: Earnings per share (EPS) are growing at a 50% pace these days, a pace which could be sustained for an extended period if the housing market finally starts to grow at a solid clip. 

  • [By Maxx Chatsko]

    Shares of construction materials leader Eagle Materials (NYSE:EXP) set new all-time highs earlier this year, although the stock’s recent surge was catalyzed by the announcement of fiscal second-quarter 2017 results in late October. At the time, the company set record revenues and more than doubled earnings per share from the prior-year period. That was followed by a new high watermark for quarterly sales in the fiscal third quarter of 2017, which ended in December, marking the third consecutive quarter in which record revenue was established.

Top 10 Stocks For 2018: Cal-Maine Foods, Inc.(CALM)

Advisors’ Opinion:

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said that Cal-Maine Foods Inc (NASDAQ: CALM) had unusually high options volume on Friday. Traders were buying the May 45 calls and Jon Najarian decided to follow the trade. He is planning to hold the position for 1 to 2 months.

  • [By Ben Levisohn]

    Cal-Maine Foods (CALM) has tumbled 6.3% to $35.00 after missing earnings forecasts.

    EXACT Sciences (EXAS) after its Cologard test was‘considered medically necessary every 3 years’ byAetna (AET). Aetna is unchanged at$126.77.

  • [By Lisa Levin]

    Cal-Maine Foods Inc (NASDAQ: CALM) posted in-line loss for its second quarter, but sales missed expectations.

    Cal-Maine Foods reported a Q2 loss of $0.48 per share on revenue of $253.5 million. Analysts were expecting a loss of $0.48 per share on revenue of $262.8 million.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Rite Aid Corporation (NYSE: RAD) to report quarterly earnings at $0.04 per share on revenue of $8.23 billion before the opening bell. Rite Aid shares gained 0.83 percent to $8.54 in after-hours trading.
    Micron Technology, Inc. (NASDAQ: MU) reported better-than-expected profit for its first quarter and issued a strong forecast for the current quarter. Micron shares climbed 9.91 percent to $22.62 in the after-hours trading session.
    Analysts expect Cal-Maine Foods Inc (NASDAQ: CALM) to post quarterly earnings at $0.48 per share on revenue of $262.83 million after the closing bell. Cal-Maine shares rose 0.12 percent to $42.75 in after-hours trading.
    Red Hat Inc (NYSE: RHT) reported upbeat earnings for its third quarter, but sales missed expectations. The company also announced that its CFO Frank Calderoni is stepping down. Red Hat shares tumbled 10.15 percent to $71.69 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Tyler Crowe, Jordan Wathen, and Beth McKenna]

    So we asked three of our contributors to highlight a stock they see as a real underdog in the market today and why investors should be watching this stock. Here’s a quick look into why they picked banker Wells Fargo (NYSE:WFC), railcar manufacturer Greenbrier Companies (NYSE:GBX) , and egg wholesaler Cal-Maine Foods (NASDAQ:CALM)

Top 10 Stocks For 2018: Renewable Energy Group, Inc.(REGI)

Advisors’ Opinion:

  • [By Manikandan Raman]

    There also some lesser known clean energy stocks that may witness downward movement on potential Trump win on negative sentiment. They include Pattern Energy Group Inc (NASDAQ: PEGI), Enviva Partners LP (NYSE: EVA), TerraForm Global Inc (NASDAQ: GLBL), Renewable Energy Group Inc (NASDAQ: REGI) and Ameresco Inc (NYSE: AMRC).

Top 10 Stocks For 2018: Unilever NV(UN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, industrial shares fell by 0.04 percent. Meanwhile, top losers in the sector included Unilever N.V. (ADR) (NYSE: UN), down 8 percent, and Magal Security Systems Ltd. (USA) (NASDAQ: MAGS), down 6 percent.

  • [By Teresa Rivas]

    Earlier this year, Unilever (UN) recently declined Kraft Heinz (KHC) merger bid. That means that if the company still wants to do a deal, Mondelez International (MDLZ) and PepsiCo (PEP) are the next logical partners, writes Susquehannas Pablo Zuanic.

    Getty Images

    Zuanic upgraded Pepsi from Neutral to Positive today and raised his price target from $118 to $132. He writes that a Pepsi deal would have more strategic merits, hence his upgrade (as he emphasizes that not much has changed in terms of fundamentals for the firm).

    More detail from his note:

    With investors apparently seeing MDLZ as the next likely KHC target, and Coca-Cola (KO) the next Anheuser-Busch (BUD) target, PEP shares have lost visibility and now trade at a 25% discount to KO on apples-to-apples comps. We see value here, on franchise strength, efforts to align the F&B portfolio with consumer health trends, and the growing optionality value of a joint KHC/BUD bid for PEP. We argue that, together, the Kendall Jenner commercial, the Aspartame to-be-or-not-to-be zigzagging, the new, new, new alt low-cal cola (Pepsi Zero sugar), the ongoing underperformance in U.S. CSDs (25% only of the company), the lack of scale in non-CSD NARTDs vs. KO (other than Gatorade), and now talk of PEP buying Brazilian dairy company Vigor S.A. (a JBS subsidiary that would better fit KHC or ULVR), all paint a picture of a company still struggling to set a new direction (with all due respect). In this regard, we think PEP may be more vulnerable than MDLZ to a KHC bid (jointly done with BUD). We also see greater strategic fit for KHC with PEP Food/Snacks (than with MDLZ), and argue that PEP Beverages fits BUD better than KO, as the PEP bottling operations in key regions (including NA) remain in the hands of PEP (KO, on the other hand will be fully refranchised by end of 2017). So we are upgrading PEP to Positive with a $132 price target by December 17. Yes, the Unilever rebuff

Top 10 Stocks For 2018: BioPharmX Corporation(BPMX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of BioPharmX Corp (NYSE: BPMX) were down 31 percent to $1.02 after the company announced the pricing of 3.6 million share common stock.

    Puma Biotechnology Inc (NYSE: PBYI) was down, falling around 22 percent to $27.53 after the company issued an update to the timeline for the filing of a new drug application. Puma Biotechnology will submit the NDA for neratinib in mid-2016. According to a press release, the decision was based on the company’s recent meetings with the U.S. Food and Drug Administration.

Top 10 Stocks For 2018: Brady Corporation(BRC)

Advisors’ Opinion:

  • [By Michael Flannelly]

    Before the opening bell on Thursday, identification solutions provider Brady Corp (BRC) posted a loss in the fourth quarter, despite a rise in revenues, as it was negatively impacted by a number of charges. However, excluding these charges, the company was able to top Wall Street analysts’ earnings and sales estimates. Nonetheless, BRC shares are plummeting in Thursday’s trading.

    The Milwaukee, Wisconsin-based company posted a loss from continuing operations of $176.2 million, or $3.41 per share, in the fourth quarter, versus last year’s fourth quarter earnings from continuing operations of $20.9 million, or 40 cents per share. Furthermore, Brady posted a net loss of $177.2 million, or $3.43 per share, compared to net earnings of $11.6 million, or 22 cents per share, in the same period a year ago.

    The fourth quarter loss includes non-cash impairment charges of $204.4 million, $15.6 million in restructuring charges, and $4 million in acquisition-related charges. Excluding these charges, Brady Corp said earnings would have been 53 cents per share in the quarter. According to analysts polled by Thomson Reuters, the company was expected to earn an adjusted 51 cents per share in the fourth quarter.

    The company’s fourth quarter sales came in at $309.1 million, up 15% from $269.1 million in sales posted last year. On average, analysts were expecting the company to see $307.13 million in revenues for the quarter.

    Looking ahead, Brady Corp. sees fiscal 2014 earnings coming in between $1.80 and $2.00 per share, below the analysts’ view of $2.30 per share.

    Brady Corp shares were down $1.71, or 5.25%, during early morning trading on Thursday. The stock is up 7.93% year-to-date.

  • [By Mike Deane]

    For the 28th year in a row, Brady Corp (BRC) has increased its dividend payout to investors.

    The Milwaukee, WI-based company increased its quarterly dividend to 19.5 cents from 19 cents, an increase of 2.6%. The annual dividend now stands at 78 cents. The quarterly dividend will be paid on October 31st, 2013 to all shareholders of record on October 10, 2013.

    BRC shares were down 40 cents, or 1.23%, by market close on Wednesday. YTD, the company’s stock is down over 4%.

  • [By Shauna O’Brien]

    Robert Baird announced on Friday that it has cut its rating on Brady Corp (BRC).

    The firm has downgraded BRC from “Outperform” to “Neutral,” and has given the company a $33 price target. This price target suggests a 8% upside from the stock’s current price of $30.52.

    Analysts see the company’s WPS segment growing faster than expected.

    Brady shares were mostly flat during pre-market trading Friday. The stock is down 9% YTD.

Top 10 Stocks For 2018: Hooker Furniture Corporation(HOFT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Hooker Furniture Corporation (NASDAQ: HOFT) shares were also up, gaining 27 percent to $39.80 after the company reported strong results for its fourth quarter.

  • [By Monica Gerson]

    Hooker Furniture Corporation (NASDAQ: HOFT) is estimated to report its quarterly earnings at $0.40 per share on revenue of $62.20 million.

    SeaChange International (NASDAQ: SEAC) is projected to post its quarterly earnings at $0.01 per share on revenue of $30.49 million.

Top 10 Stocks For 2018: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Monica Gerson]

    Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

  • [By Monica Gerson]

    Analysts are expecting Exelon Corporation (NYSE: EXC) to have earned $0.68 per share on revenue of $7.52 billion in the latest quarter. Exelon shares rose 0.34 percent to close at $35.38 on Thursday.

  • [By Horizon Investments]

    For the past year, Exelon Corp. (EXC) has had a roller coaster ride, with the stock having plummeted 15% since September 2012 – the company had announced a dividend cut of 41%, which led to a drop in the share price. Separately, the recent weak PJM auction prices did not bode well for the company. However, I believe the worst is priced in the stock price, and the company’s management is committed to improving its financial flexibility and cost structure in order to strengthen its financial performance. Also, the company is planning to incur capital expenditure (CAPEX) in the upcoming years, which will result in rate base growth for Exelon.

  • [By Casey Wilson]

    That brings us to General Electric Co. (NYSE: GE). The 125-year-old American mainstay signed a deal with Exelon Corp. (NYSE: EXC) last fall for the energy utility to use its own predictive analytics software, fittingly dubbed “Predix.”

  • [By Lisa Levin]

    Utilities shares climbed by 0.64 percent in trading on Friday. Meanwhile, top gainers in the sector included Exelon Corporation (NYSE: EXC), and FirstEnergy Corp. (NYSE: FE).

Top 10 Stocks For 2018: Pebblebrook Hotel Trust(PEB)

Advisors’ Opinion:

  • [By Marshall Hargrave]

    The other key benefit for Strategic is that it enjoys industry-leading earnings before interest, taxes, depreciation and amortization (EBITDA) per available room. For 2012, Strategic generated $81 per room of EBITDA. Compare this to top comps LaSalle Hotel (NYSE: LHO) at $74 per room and Pebblebrook Hotel Trust (NYSE: PEB) at $71. The reason for this is that Strategic is much less reliant than its peers on rooms, with much greater exposure to food and beverages. Strategic earns 53% of its revenue from rooms, while its peers get around 66% of revenues from rooms.